These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 39291425
21. Predictive values of bilirubin for in-hospital adverse events in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention. Ying C, Liu CF, Guo DQ, Du ZR, Wei YJ. Clinics (Sao Paulo); 2023; 78():100306. PubMed ID: 37949037 [Abstract] [Full Text] [Related]
22. The predictive value of the nomogram model of clinical risk factors for ischemia-reperfusion injury after primary percutaneous coronary intervention. Wang Z, Peng J. Sci Rep; 2023 Mar 28; 13(1):5084. PubMed ID: 36977721 [Abstract] [Full Text] [Related]
23. Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis. Zhang S, Diao J, Qi C, Jin J, Li L, Gao X, Gong L, Wu W. BMC Cardiovasc Disord; 2018 May 02; 18(1):75. PubMed ID: 29716535 [Abstract] [Full Text] [Related]
25. Construction and validation of a predictive model for major adverse cardiovascular events in the long term after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Yang Y, Yin X, Zhang Y, Ren L. Coron Artery Dis; 2024 Sep 01; 35(6):471-480. PubMed ID: 38656258 [Abstract] [Full Text] [Related]
26. PTH Predicts the in-Hospital MACE After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction. Wu ZF, Su WT, Chen S, Xu BD, Zong GJ, Fang CM, Huang Z, Hu XJ, Wu GY, Ma XL. Ther Clin Risk Manag; 2023 Sep 01; 19():699-712. PubMed ID: 37641783 [Abstract] [Full Text] [Related]
33. The predictive value of the triglyceride glucose index combined with cystatin C for the prognosis of patients with acute coronary syndrome. Wang C, Liao P, Tang C, Chen C, Zhang X. Front Endocrinol (Lausanne); 2024 Sep 01; 15():1423227. PubMed ID: 39257901 [Abstract] [Full Text] [Related]
34. Multimodal data-driven prognostic model for predicting new-onset ST-elevation myocardial infarction following emergency percutaneous coronary intervention. Tang L, Wu M, Xu Y, Zhu T, Fang C, Ma K, Wang J. Inflamm Res; 2023 Sep 01; 72(9):1799-1809. PubMed ID: 37644338 [Abstract] [Full Text] [Related]
38. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study. Zhao X, Wang Y, Chen R, Li J, Zhou J, Liu C, Zhou P, Sheng Z, Chen Y, Song L, Zhao H, Yan H. Cardiovasc Diabetol; 2021 Jun 28; 20(1):131. PubMed ID: 34183007 [Abstract] [Full Text] [Related]
40. Sex-Related Differences in Short- and Long-Term Outcome among Young and Middle-Aged Patients for ST-Segment Elevation Myocardial Infarction Underwent Percutaneous Coronary Intervention. Fu WX, Zhou TN, Wang XZ, Zhang L, Jing QM, Han YL. Chin Med J (Engl); 2018 Jun 20; 131(12):1420-1429. PubMed ID: 29893358 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]